Inflammatory Bowel Disease and malignancy: What are the predictors of malignancy in Inflammatory Bowel Disease?

被引：0
|
作者：
Istemihan, Z. [1 ]
Cavus, B. [1 ]
Bardak, A. E. [2 ]
Kirkoglu, A. M. [2 ]
Kiziltas, C. [2 ]
Silay, R. [2 ]
Senkal, I. V. [1 ]
Imanov, Z. [1 ]
Nuriyev, K. [1 ]
Rustemzade, A. [1 ]
Genc, S. [1 ]
Gulluoglu, M. [3 ]
Ormeci, A. Cifcibasi [1 ]
Demir, K. [1 ]
Besisik, F. [1 ]
Kaymakoglu, S. [1 ]
Akyuz, F. [1 ]
机构：
[1] Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Div Gastroenterohepatol, Istanbul, Turkiye
[2] Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Istanbul, Turkiye
[3] Istanbul Univ, Istanbul Fac Med, Dept Pathol, Istanbul, Turkiye
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P316
引用
收藏
页码：456 / 456
页数：1
相关论文
共 50 条
  • [21] Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients
    Nabeel Khan
    Carlos Vallarino
    Trevor Lissoos
    Umar Darr
    Michelle Luo
    Drugs & Aging, 2017, 34 : 859 - 868
  • [22] Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients
    Khan, Nabeel
    Vallarino, Carlos
    Lissoos, Trevor
    Darr, Umar
    Luo, Michelle
    DRUGS & AGING, 2017, 34 (11) : 859 - 868
  • [23] Spiral CT derived perfusion measurements of the bowel wall in intestinal malignancy and inflammatory bowel disease
    Harvey, CJ
    Fidler, H
    Gillams, AR
    Bonsi, D
    Bloom, S
    Lees, WR
    RADIOLOGY, 1998, 209P : 368 - 369
  • [24] INFLAMMATORY BOWEL DISEASES AND THEIR RELATIONSHIP TO MALIGNANCY
    FAINTUCH, J
    LEVIN, B
    KIRSNER, JB
    CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1985, 2 (04): : 323 - 353
  • [25] Biologic Choice Should Be Guided by Disease Severity Not Malignancy in Patients With Inflammatory Bowel Disease
    Zhou, Annie
    Srinivasan, Ashish
    Vasudevan, Abhinav
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (03) : 670 - 672
  • [26] AMYLOIDOSIS MASQUERADING AS INFLAMMATORY BOWEL-DISEASE WITH A MASS LESION SIMULATING A MALIGNANCY
    JOHNSON, DH
    GUTHRIE, TH
    TEDESCO, FJ
    GRIFFIN, JW
    ANTHONY, HF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1982, 77 (03): : 141 - 145
  • [27] Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease
    Masunaga, Yukari
    Ohno, Keiko
    Ogawa, Ryuichi
    Hashiguchi, Masayuki
    Echizen, Hirotoshi
    Ogata, Hiroyasu
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (01) : 21 - 28
  • [28] MALIGNANCY RISK IN VETERAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE COHORT STUDY
    Gandle, Cassandra
    Hou, Jason K.
    GASTROENTEROLOGY, 2019, 156 (03) : S48 - S48
  • [29] PREDICTING NEW OR RECURRENT CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND A HISTORY OF MALIGNANCY
    Gangasani, Nikitha
    Vedamurthy, Amar
    Ananthakrishnan, Ashwin
    GASTROENTEROLOGY, 2021, 160 (06) : S532 - S532
  • [30] Risk of Malignancy in Pediatric Inflammatory Bowel Disease: Results From the DEVELOP Registry
    Hyams, Jeffrey S.
    Dubinsky, Marla
    Baldassano, Robert N.
    Colletti, Richard B.
    Cucchiara, Salvatore
    Escher, Johanna
    Faubion, William
    Fell, John
    Gold, Benjamin D.
    Griffiths, Anne M.
    Koletzko, Sibylle
    Kugathasan, Subra
    Markowitz, James
    Ruemmele, Frank
    Veereman, Gigi
    Winter, Harland
    Masel, Nicholas
    Tang, Kezhen L.
    Thayu, Meena
    GASTROENTEROLOGY, 2016, 150 (04) : S131 - S131
12345